Caris Life Sciences, Inc. (CAI) fundamentals score
Caris Life Sciences is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. It develops and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Services-Medical Laboratories · Healthcare · Listed on NASDAQ
Overall: 7.3 out of 10, Good long-term fundamentals
- Growth: 6.3/10
- Profitability: 8.3/10
- Financial health: 8.1/10
- Earnings quality: 8.5/10
- Valuation: 5.2/10
Scores are calculated from Caris Life Sciences, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10